Related Experiment Video
Updated: Dec 18, 2025
09:18
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
10.7K
Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report
V A Sansone1, M C Walter2, S Attarian3
1The NEMO Clinical Center, Milan - Neurorehabilitation Unit, University of Milan, Italy.
Journal of Neuromuscular Diseases
|June 16, 2020
Summary
Nusinersen shows therapeutic benefits and a favorable safety profile in adult spinal muscular atrophy (SMA) patients. Real-world data indicate improvements in motor function, enhancing daily life and quality of life for individuals with SMA.
Area of Science:
- Neurology
- Genetics
- Pharmacology
Background:
- Spinal muscular atrophy (SMA) is a genetic motor neuron disease impacting survival motor neuron 1 (SMN1) gene function.
- Current therapies aim to boost SMN protein levels through various mechanisms.
- Nusinersen, an antisense oligonucleotide, is FDA/EMA-approved for all SMA subtypes.
Purpose of the Study:
- To evaluate the real-world effectiveness and safety of Nusinersen in adult SMA patients.
- To address the limited clinical trial data for adult SMA populations.
- To discuss diagnostic and management strategies for adult SMA.
Main Methods:
- Analysis of real-world data from neuromuscular clinical centers.
- Review of treatment effects in adult SMA patients.
- Discussion of expert recommendations from a 2019 meeting.
Main Results:
- Nusinersen demonstrated a therapeutic benefit and favorable safety profile in adult SMA patients.
- Improvements in motor function were observed, potentially enhancing autonomy and quality of life.
- Challenges in monitoring adult SMA patients due to pediatric-focused assessment tools were highlighted.
Conclusions:
- Nusinersen offers a promising therapeutic option for adult SMA patients, supported by real-world evidence.
- Further research and validated assessment tools are needed for optimal monitoring in adults.
- Standardized diagnostic and management guidelines are crucial for adult SMA care.
